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Malaria-specific antibody responses are short lived in
children, leaving them susceptible to repeated bouts
of febrile malaria. The cellular and molecular mecha-
nisms underlying this apparent immune deficiency
are poorly understood. Recently, T follicular helper
(Tfh) cells have been shown to play a critical role in
generating long-lived antibody responses. We show
that Malian children have resting PD-1+CXCR5+CD4+
Tfh cells in circulation that resemble germinal center
Tfh cells phenotypically and functionally. Within this
population, PD-1+CXCR5+CXCR3 Tfh cells are su-
perior to Th1-polarized PD-1+CXCR5+CXCR3+ Tfh
cells in helping B cells. Longitudinally, we observed
that malaria drives Th1 cytokine responses, and
accordingly, the less-functional Th1-polarized Tfh
subset was preferentially activated and its activation
did not correlate with antibody responses. These
data provide insights into the Tfh cell biology underly-
ing suboptimal antibody responses to malaria in
children and suggest that vaccine strategies that
promote CXCR3 Tfh cell responses may improve
malaria vaccine efficacy.
INTRODUCTION
The mosquito-borne Plasmodium falciparum parasite causes an
estimated 200 million cases of malaria and 600,000 deaths each
year, predominantly among African children (W.H.O., 2014).
Several studies in malaria-endemic areas have demonstrated
that children generally have short-lived antibody responses to
P. falciparum infection, leaving them susceptible to repeated
bouts of malaria (Portugal et al., 2013). Moreover, the most clin-
ically advanced malaria vaccine candidate induces short-livedCantibody responses (Alonso et al., 2005; Riley and Stewart,
2013) and confers only partial, short-term protection against ma-
laria in African children (Rts, 2014). The mechanisms underlying
short-lived antibody response to both natural malaria infection
and candidate malaria vaccines, particularly in African children,
are poorly understood—a critical knowledge gap that hinders
the development of a highly effective malaria vaccine (Crompton
et al., 2014; Langhorne et al., 2008).
In general, it is well-established that long-lived, high-affinity
antibody responses, which are induced by many pathogens
and vaccines after a single or few exposures (Amanna et al.,
2007), depend on the generation of long-lived plasma cells
(LLPCs) and memory B cells (MBCs) within germinal centers
(GCs) of secondary lymphoid organs (Tarlinton and Good-Ja-
cobson, 2013). In the GC, follicular helper T (Tfh) cells, which ex-
press high levels of CXCR5 (Breitfeld et al., 2000; Schaerli et al.,
2000) and the transcription factor Bcl6 (Johnston et al., 2009;
Nurieva et al., 2009; Yu et al., 2009), provide critical support for
the differentiation of naive B cells into isotype-switched, affin-
ity-matured LLPCs and MBCs through their production of cyto-
kines such as IL-4 and IL-21 and co-stimulatory molecules such
as CD40L (Crotty, 2014). After providing help to B cells, GC Tfh
cells may exit the GC, downregulate Bcl6, and become memory
CXCR5+CD4+ Tfh cells that recirculate in blood and then return
to the GC upon antigen re-exposure (Hale et al., 2013; Kitano
et al., 2011; Shulman et al., 2013), although it is not required
that a Tfh cell progresses through a GC Tfh state to become a
memory Tfh cell (He et al., 2013). Studies in healthy adults
have shown that circulating memory CXCR5+CD4+ Tfh cells
resemble GC Tfh cells in their capacity to produce IL-21 and
induce B cell differentiation (Chevalier et al., 2011; Ma and Dee-
nick, 2014; Morita et al., 2011). Although circulating Tfh cell sub-
populations are diverse (Schmitt and Ueno, 2013), recent work in
healthy adults identified circulating PD-1+CXCR3CXCR5+ Tfh
cells as the most closely related to bona fide GC Tfh cells by
gene expression, cytokine profile, and functional capacity (Locci
et al., 2013). Whether these observations hold true in children isell Reports 13, 425–439, October 13, 2015 ª2015 The Authors 425
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unknown—an important knowledge gap given that children are
the primary target population for most vaccines, including candi-
date malaria vaccines. Furthermore, studies of Tfh cells in hu-
mans to date have been limited to healthy individuals following
immunization (Bentebibel et al., 2013) or cross-sectional ana-
lyses of individuals with primary or acquired immunodeficiency
(i.e., HIV; Cubas et al., 2013), autoimmunity, or various cancers
(Ma and Deenick, 2014), whereas longitudinal studies of Tfh re-
sponses before, during, and after an acute natural infection
have not been published.
Despite the critical role of Tfh cells in humoral immunity and
the enormous disease burden of malaria worldwide, there are
no published studies of Tfh cells in human malaria to date
(Perez-Mazliah and Langhorne, 2014). Notably, in mousemodels
of malaria, immunotherapy targeting Tfh cells through blockade
of PD-L1 and LAG-3 augmented Tfh cell and GC B cell fre-
quencies, increased antibody levels, and accelerated the clear-
ance of blood-stage malaria parasites (Butler et al., 2011).
Conversely, simultaneously activating OX40 and blocking PD-1
signaling revealed that excessive IFN-g limits Tfh responses
and humoral anti-Plasmodium immunity (Zander et al., 2015).
Finally, it was recently reported that disruption of IL-21 signaling
inmice affects T cell-B cell interactions and abrogates protective
humoral immunity to malaria (Pe´rez-Mazliah et al., 2015).
Together, these reports identify pathways to potentially manipu-
late Tfh cells in humans to improve the efficacy of vaccines tar-
geting malaria and other pathogens.
Here, we demonstrate that circulating memory PD-1+CXCR5+
CD4+ Tfh cells in malaria-exposed children possess phenotypic
and functional characteristics of GC Tfh cells. In these children,
the PD-1+CXCR5+CXCR3 Tfh cell subset is superior to the Th1-
polarized PD-1+CXCR5+CXCR3+ Tfh cell subset in providing
B cell help. We show longitudinally that acute malaria drives a
Th1 cytokine response and, accordingly, preferentially activates
the less-functional Th1-polarized PD1+CXCR5+CXCR3+ Tfh cell
subset, consistent with a lack of correlation between Tfh cell re-
sponses and plasma cell/antibody responses to malaria in the
same children.
RESULTS
Malian Children Maintain Resting Blood
PD-1+CXCR5+CD4+ Memory T Cells that Resemble GC
Tfh Cells in Phenotype and IL-21 Production Capacity
Studies of healthy adults have shown that blood CXCR5+CD4+
T cells are the circulating counterparts of GC Tfh cells in second-Figure 1. PD-1-Expressing CXCR5+CD4+ T Cells from Malian Children
(A) Longitudinal study design in which blood was collected at the healthy uninf
episode of the ensuing malaria season (acute), and 7 days post-malaria treatme
(B and C) The percentage of CXCR5+ cells within total circulating lymphocytes a
(D) Gating strategy for CD45RO+CD45RACXCR5+ CD4+ T helper cell subsets.
(E) Distribution of memory CXCR5+ T cell subsets in Malian children and US adu
(F) Intracellular IL-21 production across CXCR5+ subsets with and without PMA/
(G) Percentage of IL-21-producing cells across CXCR5+ subsets following PMA/
(H) Intracellular IL-2 and TNF production across CXCR5+ subsets with and witho
(I) Percentage CXCR5+ subsets producing intracellular IL-2 and TNF following P
p values were determined by Student’s t test with Bonferroni corrections for multi
where appropriate. ****p < 0.0001; ***p < 0.001; **p < 0.01; *p < 0.05; ns, not sig
Cary lymphoid tissue (Chevalier et al., 2011; He et al., 2013; Morita
et al., 2011), cells that support the development of high-affinity,
long-lived antibody responses. Children exposed to intense ma-
laria transmission tend to have short-lived P. falciparum-specific
antibody responses and suffer repeated bouts of febrile malaria
each year (Crompton et al., 2010; Portugal et al., 2013). To inves-
tigate Tfh cells in the context of pediatric malaria, we took advan-
tage of the sharply demarcated 6-month rainy season (intense
malaria transmission) and 6-month dry season (negligible ma-
laria transmission) in Mali to conduct a longitudinal analysis of
circulating Tfh cells in children beginning at their healthy unin-
fected baseline at the end of the dry season and the same chil-
dren during their first acute febrile malaria episode of the ensuing
malaria season (Figure 1A).
We first asked whether children residing in a malaria-endemic
area show evidence of a general deficiency in generating and
maintaining resting memory CXCR5+CD4+ T cells by analyzing
blood samples from healthy uninfected children (n = 25) at the
end of the 6-month dry season. Characteristics of these children
are summarized in Table S1. In parallel, we analyzed blood from
healthy US adults (n = 15) as a benchmark to compare with pub-
lished studies. Consistent with previous observations (Breitfeld
et al., 2000; He et al., 2013; Morita et al., 2011), we found in
both Malian children and US adults that 15%–20% of circulating
antigen-experienced (CD45RO+) CD4+ T cells express CXCR5
(Figures 1B and 1C), indicating that the inefficient acquisition
of humoral immunity to malaria in children is not due to a global
deficiency in generating and maintaining antigen-experienced
CXCR5+CD4+ T cells in blood.
More recent work in healthy adults demonstrated that, within
the blood CXCR5+CD4+ memory T cell population, the PD-
1+CXCR3CXCR5+ subset most closely resembles bona fide
GC Tfh cells, both phenotypically and functionally (Locci et al.,
2013). Therefore, we asked whether the PD-1+CXCR3CXCR5+
T cell subset could be detected in the peripheral blood of healthy
Malian children at the end of the dry season. Similar to observa-
tions in healthy adults (Locci et al., 2013), we found that the
majority of antigen-experienced CXCR5+CD4+ T cells were
PD-1 (Figure 1D). In comparing Malian children to US adults,
we found the percentage of PD-1+CXCR3CXCR5+ T cells as
well as the overall distribution of CXCR5+CD4+ T cell subsets
to be similar between the two groups (Figure 1E). Next, we deter-
mined the distribution of central memory (TCM) and effector
memory (TEM) cells among the CXCR5+CD4+ T cell subsets in
children at their healthy baseline before the malaria season.
CD45RO+CD4+ T cells are generally categorized as TCM orHave Features of GC Tfh Cells
ected baseline before the malaria season (HB), during the first acute malaria
nt (7dpt).
nd antigen-experienced CD4+ T cells in Malian children and US adults.
lts.
ionomycin in representative Malian child and US adult.
ionomycin stimulation in Malian children (n = 10) and US adults (n = 8).
ut PMA/ionomycin in representative Malian child and US adult.
MA/ionomycin stimulation in Malian children (n = 10) and US adults (n = 10).
ple comparisons or by ANOVA with Sidak corrections for multiple comparisons
nificant.
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TEM cells on the basis of differential CCR7 expression (Sallusto
et al., 1999). TCM cells express CCR7 and home to secondary
lymphoid tissue, whereas TEM cells do not express CCR7 and
migrate to sites of inflammation. Consistent with prior studies
(Breitfeld et al., 2000; Chevalier et al., 2011; Locci et al., 2013),
we identified the majority of CD45RO+CXCR5+CD4+ T cells as
TCM cells (Figure S1A). Also comparable with prior work (Locci
et al., 2013), both the PD-1+CXCR3CXCR5+ and PD-
1+CXCR3+CXCR5+ subsets had a higher percentage of TEM
compared to the PD-1 subsets (Figures S1A and S1B). Thus,
these data indicate that children in malaria-endemic Mali are
capable of generating and maintaining memory PD-1+CXCR3
CXCR5+ T cells.
Although circulating PD-1+CXCR3CXCR5+ memory T cells
are clearly detectable in Malian children, it remained possible
that these cells lacked other phenotypic markers of GC Tfh cells
or the capacity to produce IL-21, the canonical GC Tfh cytokine
that drives B cell differentiation (Linterman et al., 2010; Zotos
et al., 2010). Therefore, we compared blood PD-1+CXCR5+CD4+
T cells to other CXCR5+CD4+ T cell subsets and non-Tfh cells
(CXCR5) by their expression of cell surface proteins (SLAMF6,
CD200, TIGIT, CD150, and CD84) and transcription factors (Bcl6
and cMaf) that characterize GC Tfh cells (Crotty, 2014; Ma and
Deenick, 2014). In Malian children, we found that a higher
percentage of both PD-1+CXCR3+CXCR5+CD4+ and PD-
1+CXCR3CXCR5+CD4+ T cells expressed SLAMF6, CD200,
TIGIT, CD150, and CD84 compared to their PD-1 counterparts
(Figure S1C), indicating that the PD-1+CXCR5+CD4+ T cell sub-
sets are more closely related to GC Tfh cells. A similar pattern
was observed in healthy US adults (Figure S1C), consistent
with previous reports (Ma et al., 2012). Also in line with prior
studies, we found that the expression of Bcl6, an essential tran-
scription factor for GC Tfh differentiation (Johnston et al., 2009;
Nurieva et al., 2009; Yu et al., 2009), was similar across the
CXCR5+ and CXCR5 T cell subsets, consistent with the notion
that Bcl6 is downregulated as GC Tfh cells exit secondary
lymphoid tissue into the peripheral circulation (Chevalier et al.,
2011; Kitano et al., 2011; Morita et al., 2011; Rasheed et al.,
2006; Shulman et al., 2013). However, the overall level of Bcl6
expression was higher inMalian children compared to US adults.
In contrast, expression of the transcription factor cMaf, which is
associated with IL-4 production and Tfh cell differentiation
(Kroenke et al., 2012), was lower in Malian children compared
to US adults, but among Malian children, cMaf expression was
higher in the PD-1+CXCR5+CD4+ T cell subsets compared to
other CXCR5+CD4+ T cell subsets (Figure S1C).Figure 2. PD-1+CXCR3CXCR5+CD4+ Tfh Cells Are Superior to PD-1+C
(A–C) PD-1+CXCR3CXCR5+CD4+ and PD-1+CXCR3+CXCR5+CD4+ Tfh cells fro
B cells (CD19+CD21+CD27) with and without SEB. After 12 days, surface ex
(A) Representative plots of IgD and IgG staining on B cells after 12-day co-culture
(C) Total IgG1–4, IgM, IgA, and IgE levels in supernatants after 12-day co-culture
(D–F) The same FACS-sorted PD-1+CXCR3CXCR5+CD4+ and PD-1+CXCR3+
(CD19+CD21+CD27+) with and without SEB. After 6 days, surface expression of
sentative plot of CD27 and CD38 staining on B cells after 6-day co-culture is sh
culture is shown. (F) Total IgG1–4, IgM, IgA, and IgE levels in supernatants after
color.
p values were determined by paired Student’s t test with Bonferroni adjustments
CNext, we compared resting blood PD-1+CXCR5+CD4+ mem-
ory T cells to other CXCR5+CD4+ T cell subsets and non-Tfh cells
for their capacity to produce IL-21. As expected, following a brief
stimulation with PMA and ionomycin, we detected a higher per-
centage of IL-21-producing cells among the PD-1+CXCR5+CD4+
T cell subsets compared to other CXCR5+CD4+ T cell subsets
and non-Tfh cells in both Malian children and US adults (Figures
1F and 1G). Interestingly, Malian children had a higher percent-
age of IL-21-producing cells across all CXCR5+CD4+ T cell sub-
sets compared to US adults (Figure 1G). Of note, intracellular
TNF and IL-2 were detectable across all subsets following stim-
ulation with PMA/ionomycin (Figures 1H and 1I), demonstrating
that the CXCR5+CD4+ T cell subsets are generally able to pro-
duce cytokines.
Together, these data indicate that children in malaria-endemic
areas are capable of generating a circulating population of
resting PD-1+CXCR5+CD4+ memory T cells that resemble GC
Tfh cells in phenotype and IL-21 production capacity.
Circulating PD-1+CXCR3CXCR5+CD4+ TCells inMalian
Children Are Superior to PD-1+CXCR3+CXCR5+CD4+
T Cells in Providing B Cell Help
The data above indicate that the inefficient acquisition of ma-
laria-specific antibodies in children cannot be explained by a
global deficiency in generating circulating PD-1+CXCR5+CD4+
memory T cells; however, it remained possible that these cells
do not function to provide B cell help in children during a malaria
infection. As noted above, others have recently shown in healthy
adults that among PD-1+CXCR5+CD4+ memory Tfh cells, the
CXCR3 subset is superior in providing B cell help (Locci et al.,
2013), a finding that we confirmed in healthy US adults (Figures
S2A–S2C). However, in children it is unknown whether blood
PD-1+CXCR5+CD4+ memory T cells can provide B cell help
and, if so, whether CXCR3 expression discriminates a differential
ability to help B cells. To determine their capacity to help B cells
in Malian children, PD-1+CXCR3+CXCR5+CD4+ and PD-1+
CXCR3CXCR5+CD4+ T cells (hereafter referred to as CXCR3+
and CXCR3 Tfh cells, respectively) were FACS sorted and
cultured with autologous naive B cells (CD19+CD21+CD27)
for 12 days with and without the superantigen SEB to mimic
the interaction between antigen-specific T cells and antigen-pre-
senting B cells (Morita et al., 2011). After 12 days without SEB,
we observed no difference in the percentages of IgDIgG+
B cells in samples co-cultured with CXCR3+ or CXCR3 Tfh cells
(Figures 2A and 2B). However, after 12 days in the presence of
SEB, there was a significantly higher percentage of IgDIgG+XCR3+CXCR5+CD4+ Tfh Cells in Providing B Cell Help
mMalian children (n = 8) were FACS sorted and cultured with autologous naive
pression of IgD and IgG on B cells and secreted Ig levels were measured.
are shown. (B) Percentage of IgDIgG+ B cells after 12-day co-culture is shown.
are shown.
CXCR5+CD4+ Tfh subsets were cultured for 6 days with autologous MBCs
CD27 and CD38 on B cells and secreted Ig levels were measured. (D) Repre-
own. (E) Percentage of B cells that were CD38hi plasmablasts after 6-day co-
6-day co-culture are shown. Samples from the same subject are matched by
. ****p < 0.0001; ***p < 0.001; **p < 0.01; *p < 0.05.
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B cells in samples co-cultured with CXCR3 versus CXCR3+ Tfh
cells (Figures 2A and 2B), suggesting that CXCR3 Tfh cells are
more efficient than CXCR3+ Tfh cells in promoting class switch-
ing. Similarly, CXCR3 Tfh cells were more efficient than their
CXCR3+ counterparts in inducing naive B cells to produce
IgG1-IgG3, IgM, IgA, and IgE antibodies (Figure 2C). However,
in the absence of SEB, naive B cells produced little or no Ig
(Figure 2C). Next, sorted CXCR3+ and CXCR3 Tfh cells
were cultured with autologous MBCs (CD19+CD21+CD27+) for
6 days with and without SEB. After 6 days without SEB, we
observed no significant difference in the percentage of CD38hi
plasmablasts in samples cultured with CXCR3+ versus CXCR3
Tfh cells (Figures 2D and 2E), whereas 6 days with SEB yielded a
significantly higher percentage of CD38hi plasmablasts in sam-
ples cultured with CXCR3 versus CXCR3+ Tfh cells (Figures
2D and 2E), suggesting that CXCR3 Tfh cells more efficiently
induce MBCs to differentiate into plasmablasts. Likewise,
CXCR3 Tfh cells were more efficient than their CXCR3+ coun-
terparts in driving MBCs to produce IgG2 and IgG4 (Figure 2F),
whereas in the absence of SEB, MBCs produced little or no Ig
(Figure 2F). The failure of CXCR3+ Tfh cells to efficiently provide
B cell help was not due to cell death as both SEB-stimulated
T cell subsets had similar percentages of viable cells after stim-
ulation (data not shown).
Together, these data show that CXCR3 Tfh cells in Malian
children exhibit superior Tfh cell functionality in helping B cells
compared to their CXCR3+ counterparts.
CXCR3+ Tfh Cells in Malian Children Are Th1 Polarized
A clearer understanding of the differential capacity of blood Tfh
cell subsets to provide B cell help could inform the development
of vaccines that generate long-lived humoral immunity. For
example, strategies that skew Tfh responses toward the more-
functional CXCR3 subset could potentially improve current ma-
laria vaccine candidates such as RTS,S, which confer short-lived
protection from malaria (Stanisic et al., 2013).
Prior work in healthy adults has shown that blood Tfh cells
comprise functionally distinct subsets that share features of
Th1, Th2, and Th17 cells, as defined by the differential expres-
sion of CXCR3 and CCR6 (Bentebibel et al., 2013; Morita et al.,
2011; Schmitt and Ueno, 2013). More specifically, it was shown
in healthy adults that CXCR3 subsets are Th2 or Th17 polarized
and provide efficient B cell help, whereas Th1-like CXCR3+ sub-
sets are poor B cell helpers (Morita et al., 2011). As noted earlier,
more-recent studies in healthy adults have demonstrated that
PD-1 expression further distinguishes Tfh subsets and identifies
the Th2-cell type PD-1+CXCR3 subset among quiescent blood
Tfh cells as the most functional in terms of providing B cell help
(He et al., 2013; Locci et al., 2013). However, it is unknown in chil-
dren, particularly those residing in malaria-endemic areas,
whether circulating PD-1+CXCR3 and PD-1+CXCR3+ subsets
are similarly polarized along the Th1/Th2/Th17 axis.
We first addressed this question in healthy uninfected children
at the end of the dry season by quantifying the expression of the
lineage-defining transcription factors T-bet, GATA3, RORgT,
and Foxp3 in antigen-experienced CXCR5+CD4+ Tfh subsets
on the basis of PD-1 and CXCR3 expression (Figure 3A). In par-
allel, as a positive control within each subject, we quantified the430 Cell Reports 13, 425–439, October 13, 2015 ª2015 The Authorsexpression of the same transcription factors in antigen-experi-
enced CXCR5CD4+ T cell subsets on the basis of CCR6 and
CXCR3 expression in order to identify Th1, Th2, and Th17 cells
(Figure 3A), as previously described (Morita et al., 2011). As ex-
pected, the percentage of cells expressing T-bet and GATA3
was higher in the CXCR5 Th1 and Th2 subsets, respectively
(Figure 3B). The percentage of cells expressing RORgT was
higher in both the CXCR5 Th1 and Th17 subsets (Figure 3B).
Among the CXCR5+ subsets, we found that a higher percentage
of PD-1+CXCR3+ cells expressed T-bet, whereas a higher
percentage of PD-1+CXCR3 cells expressed GATA3 (Fig-
ure 3B). The expression of RORgT and Foxp3 was similar across
CXCR5+ subsets (Figure 3B).
We then measured cytokines corresponding to lineage-
defining transcription factors after PMA/ionomycin stimulation.
As expected, the CXCR5 Th1, Th2, and Th17 subsets ex-
pressed IFN-g, IL-4/IL-13, and IL-17, respectively (Figure 3C).
Predictably, PD-1+CXCR3+CXCR5+ cells expressed IFN-g,
whereas the PD-1+CXCR3CXCR5+ subset produced almost
no IFN-g (Figure 3C). Unexpectedly, PD-1+CXCR3CXCR5+
cells, which had a higher percentage of GATA3-expressing cells,
did not express higher levels of IL-4 or IL-13 compared to
PD-1+CXCR3+CXCR5+cells (Figure 3C), possibly due to low
expression of cMaf in Malian children (Figure S1C), a transcrip-
tion factor essential for IL-4 production (Kroenke et al., 2012).
We observed no difference in the percentage of cells producing
IL-10 or IL-17 across the subsets (Figure 3C).
Together, these data indicate that, in Malian children, circu-
lating PD-1+CXCR3+CXCR5+ Tfh cells are Th1 skewed whereas
PD-1+CXCR3CXCR5+ Tfh cells are not as clearly Th2 skewed
as those reported in healthy adults.
Acute Malaria Drives a Th1 Cytokine Response and
Preferentially Activates the Less-Functional
Th1-Polarized CXCR3+ Tfh Subset
Given that children in areas of intense P. falciparum transmission
tend to have short-lived antibody responses to malaria, we hy-
pothesized that acute malaria would preferentially activate the
less-functional Th1-polarized CXCR3+ Tfh subset. In general,
circulating antigen-experienced CXCR5+CD4+ T cells in healthy
individuals are considered to be restingmemory Tfh cells and ex-
press moderate levels of PD-1 and low levels of the proliferation/
activation markers Ki67, CD38, HLA-DR, and inducible T cell co-
stimulator (ICOS)—in contrast to their activated GC Tfh cell
counterparts in secondary lymphoid tissue that express high
levels of these markers (Crotty, 2014). Previous work showed
that, like other memory T helper cells, memory Tfh cells can be
recalled during antigen re-exposure and preferentially become
effector Tfh cells and GC Tfh cells upon reactivation (Hale
et al., 2013). Therefore, to test the hypothesis that acute
malaria preferentially activates the less-functional Th1-polarzied
CXCR3+ Tfh subset, we analyzed thawed PBMCs collected from
children at their healthy uninfected baseline at the end of the
6-month dry season and from the same children during their first
episode of febrile malaria during the ensuing 6-month malaria
season—a prospective analysis made possible by the intense
and sharply demarcated malaria season at the study site (Tran
et al., 2013). At the first malaria episode, children were febrile
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Figure 3. PD-1+CXCR3+CXCR5+CD4+ Tfh Cells Are Th1 Polarized
(A) Gating strategy for the analysis of CXCR5+ and CXCR5 memory CD4+ T cell subsets.
(B) Ex vivo expression of T-bet, GATA-3, RORgT, and Foxp3 by CXCR5+ and CXCR5 CD4+ T cell subsets.
(C) Intracellular production of indicated cytokines by CXCR5+ and CXCR5 CD4+ T cell subsets following PMA/ionomycin stimulation.
Only PD1+CXCR3+ and PD1+CXCR3were compared, and p values were determined by paired Student’s t test. ****p < 0.0001; ***p < 0.001; **p < 0.01; *p < 0.05.or reported fever within 24 hr, were infected with P. falciparum
(geometric mean: 29,991 asexual parasites/ml of blood), and
had no other cause of fever discernible on physical examination.
All subjects were treated with a standard 3-day course of arte-
mether/lumefantrine. Characteristics of subjects are shown in
Table S1.
Consistent with our hypothesis, we found that only the less-
functional Th1-polarized CXCR3+ Tfh memory cells were
activated and proliferated in response to acute malaria, as evi-
denced by a significant increase in the percentage of cells ex-
pressing Ki67, CD38, and HLA-DR (Figures 4A–4C). Of note,
the majority of activated CXCR3+ Tfh cells were double positive
for these markers (Figures S3A–S3C), indicating that this popu-
lation is homogeneously activated. Besides the crucial role
ICOS plays in Tfh development (Akiba et al., 2005) and functionC(Vogelzang et al., 2008), recent studies suggest that ICOS-ex-
pressing Tfh cells migrate toward B cells expressing ICOS
ligand (ICOS-L) to initiate the formation of GCs (Xu et al.,
2013). Interestingly, acute malaria was associated with a signif-
icant increase in ICOS expression only on CXCR3+ Tfh cells
(Figure 4D).
Next, we asked whether the increase in activation markers in
CXCR3+ Tfh cells during acute malaria reflected the appear-
ance of pre-GC Tfh effector cells (CCR7loPD-1hi) in circulation,
as recently described in the context of influenza vaccination
(He et al., 2013). Contrary to this hypothesis, acute malaria
did not change the percentage of circulating CCR7loPD-1hi
cells within the CXCR5+ subset (Figures 4E and 4F) and was
associated with a decrease in circulating CCR7loPD-1hi cells
within the CXCR3+ subset (Figure 4G), suggesting that theell Reports 13, 425–439, October 13, 2015 ª2015 The Authors 431
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Figure 5. PD-1+CXCR3+CXCR5+CD4+ T Cells Transiently Decrease
in Circulation during Acute Malaria
(A and B) Percentage of circulating (A) PD-1+CXCR3+CXCR5+CD4+ and (B)
PD-1+CXCR3CXCR5+CD4+ T cells in Malian children at the healthy baseline
(HB), during acute malaria (acute), and 7dpt.
(C) Fold change in percentage of circulating PD-1+CXCR3+CXCR5+CD4+ and
PD-1+CXCR3CXCR5+CD4+ T cells from HB to acute.
p values were determined by paired-design ANOVA with Tukey adjustments
for multiple comparisons where appropriate. ****p < 0.0001; ***p < 0.001;
**p < 0.01; *p < 0.05.increase in activation/proliferation markers in the CXCR3+ pop-
ulation did not arise from newly generated pre-GC Tfh effector
cells.CTo gain insight into why the less-functional Th1-polarized
CXCR3+ Tfh subset is preferentially triggered during malaria,
we measured cytokines in plasma collected from the same chil-
dren at their uninfected baseline before the malaria season and
during acute malaria. We found that the Th1 cytokines IFN-g,
IL-12p70, IL-18, and TNF were significantly increased in plasma
during acute malaria compared to baseline (Figure 4H), whereas
the Th2 cytokines IL-4, IL-5, and IL-13 were not detectable at
either time point (data not shown), consistent with the preferen-
tial activation of Th1-polarized CXCR3+ Tfh cells during malaria.
One possible outcome of activating blood Tfh memory cells is
their migration to secondary lymphoid organs to provide B cell
help in GCs. Indeed, studies in mice have demonstrated that
an increase in activated blood Tfh cells correlates with increased
frequencies of newly generated Tfh cell in secondary lymphoid
organs (He et al., 2013). We tested this hypothesis indirectly by
longitudinally tracking the kinetics of CXCR3+ and CXCR3 Tfh
cells in children before, during, and 7 days after treatment of
an acute malaria episode. We found that CXCR3+ Tfh cells (the
subset that proliferated in response to malaria) transiently
decreased in blood during acute malaria (Figures 5A–5C), sug-
gesting that malaria-induced activation of CXCR3+ Tfh cells
results in their migration from blood to secondary lymphoid
tissues.
P. falciparum Stimulation of PBMCs Recapitulates
Acute Malaria by Inducing Th1 Cytokines and
Preferentially Activating CXCR3+ Tfh Cells
To further test the hypothesis that acute malaria preferentially
drives the expansion of memory CXCR3+ Tfh cells, rather than
forming effector cells de novo with each infection, we stimulated
PBMCs collected from uninfected children (before malaria sea-
son) with a prior history of malaria exposure with P. falciparum-
infected red blood cells (iRBCs) for 5 days. Consistent with the
ex vivo data obtained during acute malaria, only the CXCR3+
population showed an increase in the activation/proliferation
markers Ki67, CD38, HLA-DR, and ICOS following in vitro stim-
ulation with iRBCs (Figures 6A and 6B), suggesting that the pref-
erential triggering of CXCR3+ Tfh cells during acute malaria is
due to activation of preexisting memory Tfh cells. Moreover, in
response to iRBC stimulation, the same PBMC samples
secreted IFN-g and TNF, but not IL-4, IL-5, or IL-13 (Figure 6C),
thus recapitulating the Th1-polarized response observed during
acute malaria.
Tfh Responses to Acute Malaria Do Not Correlate with
Plasma Cell or Antibody Responses
Others have recently shown in humans that circulating Tfh cell
responses correlate with antibody responses to influenza vacci-
nation (Bentebibel et al., 2013) and the development of broadly
neutralizing antibodies against HIV (Locci et al., 2013). Because
malaria preferentially activates the less-functional CXCR3+ Tfh
subset, we hypothesized that Tfh cell responses to malaria
would not correlate with B cell and antibody responses induced
by the same infection. We tested this hypothesis by examining
longitudinally the relationship between Tfh cell responses to
acute malaria and plasma cell (PC) and antibody responses to
the same infection. We quantified total PCs, short-lived plasmaell Reports 13, 425–439, October 13, 2015 ª2015 The Authors 433
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cells (SLPCs), and LLPCs (Figure S4) in the peripheral blood
of children at baseline, during the first malaria episode of
the ensuing malaria season, and 7 days post-malaria treatment.
Tfh subsets were enumerated in the same samples at
baseline and during acute malaria. Compared to baseline, PCs
and SLPCs increased during malaria, whereas an increase
in LLPCs was not detected until day 7 post-malaria (Fig-
ure 7A). We observed no significant correlation between fold
changes in CXCR3+ or CXCR3 Tfh cells from baseline to
acute malaria and fold changes in PCs, SLPCs, or LLPCs (Fig-
ures 7B and 7C).
We then asked whether Tfh responses to malaria correlate
with the breadth or magnitude of P. falciparum-specific IgG re-
sponses. By protein microarray (Crompton et al., 2010), we
measured plasma IgG to 1,087P. falciparum antigens at baseline
and 7 days post-malaria treatment. As expected, the breadth of
P. falciparum-specific antibody responses (the number of anti-
gens to which IgG reactivity exceeded 2 SD above the negative
control) increased 7 days post-malaria compared to baseline
(Figure 7D), but there was no correlation between fold changes
in CXCR3+ or CXCR3 Tfh cells and fold changes in antibody
breadth (Figures 7E and 7F). We also observed a significant in-
crease in the overall magnitude of IgG reactivity to P. falciparum
antigens 7 days post-malaria compared to baseline (Figure 7G),
but again there was no correlation between fold changes in
CXCR3+ or CXCR3 Tfh cells and the magnitude of antibody re-
sponses to malaria (Figures 7H and 7I).
Collectively, the lack of correlation between Tfh cell responses
and B cell and antibody responses to malaria is consistent with
the observation that acute malaria preferentially activates the
less-functional CXCR3+ Tfh cell subset.
DISCUSSION
Tfh cells are essential for generating high-affinity, long-lived anti-
body responses (Crotty, 2014; Ma and Deenick, 2014), and
therefore, there is considerable interest in understanding how
Tfh memory cells are generated and maintained in humans.
This is particularly true for infections like malaria, HIV, and TB
that impose enormous disease burdensworldwide and for which
there are no highly effective licensed vaccines (Rappuoli and
Aderem, 2011). In the case of malaria, antibody responses to
natural P. falciparum infections in children tend to be short-lived,
leaving children susceptible to repeated bouts of febrile malaria
(Portugal et al., 2013). Here, we studied the nature of Tfh re-
sponses tomalaria in children that underlies the inefficient acqui-
sition of protective, long-lived antibodies. More generally, we
sought to determine whether recently published findings on
blood Tfh cells in adults hold true in children, because childrenFigure 6. P. falciparum-Infected RBCs Drive a Th1 Cytokine Response
PBMCs collected before the malaria season from healthy uninfected children with
blood cells (iRBCs) or naive red blood cells (nRBCs) for 5 days.
(A) Representative plots showing the expression of Ki67, HLA-DR, CD38, and IC
(B) MFI of Ki67, HLA-DR, CD38, and ICOS in the PD-1+CXCR3+ and PD-1+CXCR
(C) Cytokine levels in supernatants of stimulated PBMCs.
p values were determined by paired-design ANOVA with Sidak corrections for m
multiple comparisons. ****p < 0.0001; ***p < 0.001; **p < 0.01; *p < 0.05.
Care the key target population for most licensed and candidate
vaccines, including candidate malaria vaccines.
In this study, we show in children that circulating memory PD-
1+CXCR5+CD4+ Tfh cells resemble GC Tfh cells phenotypically
and functionally. We demonstrate that the CXCR3 Tfh cell sub-
set is superior to the Th1-polarized CXCR3+ Tfh cell subset in
providing B cell help in vitro, consistent with recent findings in
healthy adults (Locci et al., 2013). We then show longitudinally
that acute malaria preferentially activates the less-functional
Th1-polarized CXCR3+ Tfh subset, in concert with a malaria-
driven Th1 cytokine response, whereas the highly functional
CXCR3 Tfh subset does not appear to be triggered by malaria.
Because only the CXCR3+ Tfh subset showed evidence of prolif-
erating during acute malaria, the decrease in CXCR3+ Tfh cells
during malaria may represent egress from circulation to second-
ary lymphoid tissues. Accordingly, we observed no correlation
between Tfh responses to malaria and the B cell and malaria-
specific antibody response to the same infection. These data
offer a functional link between Tfh cells and suboptimal antibody
responses to malaria in children and are consistent with the hy-
pothesis that malaria induces short-lived, low-affinity antibody
responses that arise in large part from extra-follicular, T-cell-in-
dependent reactions (Tarlinton and Good-Jacobson, 2013). It
will be of interest in future studies to test the hypothesis that
the gradual transition from non-protective to protective antibody
responses from childhood to adulthood is due to contraction of
CXCR3+ Tfh cells and expansion of themore-functional CXCR3
Tfh cells.
Acute malaria was not associated with an increase in circu-
lating pre-GC Tfh effector cells (CCR7loPD-1hi), as recently
described in influenza vaccinees (He et al., 2013). This result,
together with the finding that CXCR3+ Tfh cells from children
with prior malaria exposure were activated by P. falciparum
in vitro, suggests that the preferential activation of CXCR3+ Tfh
cells during acute malaria is due to the expansion of preexisting
memory Tfh cells, rather than the induction of newly generated
pre-GC Tfh effector cells. Elucidating the precise conditions fa-
voring the expansion of pre-GC Tfh effector cells in somemodels
and not others requires further investigation.
Unexpectedly, we found that CXCR3 Tfh cells in African chil-
dren were not as clearly Th2 polarized as CXCR3 Tfh cells in
healthy adults (He et al., 2013; Kroenke et al., 2012; Locci
et al., 2013). In line with this observation, we found that cMaf
expression, which is required for IL-4 production (Kroenke
et al., 2012), is lower in Tfh cells of Malian children compared
to healthy adults. These potentially important differences be-
tween malaria-exposed and non-exposed children and adults
merit further investigation and may have implications for vaccine
strategies.and Preferentially Activate CXCR3+ Tfh Cells
prior malaria exposure were stimulated in vitro with P. falciparum-infected red
OS in the PD-1+CXCR3+ and PD-1+CXCR3 subsets following stimulation.
3 subsets following stimulation.
ultiple comparisons or paired Student’s t test with Bonferroni corrections for
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Previous studies in mice and humans have shown that acute
Plasmodium blood-stage infection drives the early activation of
Th1 cells that, in mouse models, are essential for early control
of parasite replication and host survival through the activation
of effector cells such as macrophages (Perez-Mazliah and Lan-
ghorne, 2014). The findings of our study suggest that Plasmo-
dium-induced Th1 cell activation manifests within the circulating
Tfh cell compartment as activation of the less-functional
CXCR3+ Th1 cell-type subset and that the survival advantage re-
sulting from early Th1-mediated control of parasite replication
may come at the expense of high-affinity, long-lived antibody re-
sponses. The notion that heterogeneity in GC Tfh cell pheno-
types is partly driven by environmental cues is reminiscent of
chronic LCMV infection inmice, in which intense Th1 polarization
drives GC Tfh cells to express T-bet and IFN-g (Johnston et al.,
2009; Yusuf et al., 2010). It is also possible that malaria induces
early Tfh cells that fail to mature into GC Tfh cells, a phenomenon
that appears to occur during Salmonella infections that are char-
acterized by high bacterial loads and excessive Th1 responses
(Cunningham et al., 2007). Consistent with this, recent work
has shown that excessive IFN-g sharply limits Tfh activity during
experimental malaria (Zander et al., 2015). It will be of interest to
further test these hypotheses in mouse models of malaria and to
elucidate the lineage, antigen specificity, and in vivo function of
Tfh subsets during Plasmodium infection.
The most clinically advanced malaria vaccine candidate,
RTS,S, targets the circumsporozoite protein (CSP) on the
surface of sporozoites—the parasite stage transmitted from
mosquitos to humans (Regules et al., 2011). RTS,S induces rela-
tively short-lived CSP-specific antibody responses (Alonso et al.,
2005; Riley and Stewart, 2013) and confers only partial, short-
term protection from malaria in children (Rts, 2014). In light of
our findings here, it is noteworthy that RTS,S induces Th1-
skewed CS-specific CD4+ T cells in children residing in
malaria-endemic areas (White et al., 2013). This raises the possi-
bility that RTS,S activates the less-functional CXCR3+ Th1 cell-
type Tfh cells, resulting in short-lived antibody responses. Going
forward, it will be critical in malaria vaccine trials to assess the
phenotype and function of circulating Tfh cells induced by vacci-
nation and how these parameters relate to antibody responses
and clinical outcomes.
In summary, we demonstrate that circulatingmemory CXCR3+
Th1 cell-type Tfh cells in children exhibit impaired B cell help and
are preferentially activated during acutemalaria. These data pro-
vide important insights into the cellular and molecular basis of
suboptimal antibody responses to malaria in children and estab-
lish a link between the quality of Tfh cell responses and theFigure 7. Tfh Cell Responses to Malaria Do Not Correlate with Plasma
(A) Circulating total PCs (CD20CD21CD27+; left), SLPCs (CD20CD21CD27
percentage of total CD19+ cells in children at healthy baseline (HB), during acute
(B) Fold change in CXCR3+ Tfh cells (HB to acute) versus fold change in total PC
(C) Fold change in CXCR3 Tfh cells (HB to acute) versus fold change in total PC
(D) Antibody breadth of IgG response to 1,087 P. falciparum antigens at HB and
(E and F) Fold change in (E) CXCR3+ or (F) CXCR3 Tfh cells from HB to acute v
(G) Total IgG reactivity to 1,087 P. falciparum antigens during HB and 7dpt.
(H and I) Fold change in (H) CXCR3+ or (I) CXCR3 Tfh cells from HB to acute ver
to 7dpt.
Student’s t test and Pearson correlation were used. ****p < 0.0001; ***p < 0.001;
Coutcome of B cell responses during a natural infection. These
findings also suggest that vaccine strategies that promote
CXCR3 Tfh cell responses may improve malaria vaccine effi-
cacy in children.
EXPERIMENTAL PROCEDURES
Human Samples
The Ethics Committee of the Faculty of Medicine, Pharmacy and Dentistry at
the University of Sciences, Technique and Technology of Bamako and the
Institutional Review Board of NIAID/NIH approved this study. Informed con-
sent was obtained from parents or guardians of participating children. The field
study, described in detail in Supplemental Experimental Procedures and else-
where (Tran et al., 2013), was conducted in Mali where intense P. falciparum
transmission occurs from June through December each year. Blood samples
were obtained from children at their healthy uninfected baseline before the
malaria season, as well as during and 7 days after treatment of their first
acute malaria episode of the ensuing 6-month malaria season. Detection of
P. falciparum infection and processing of blood samples is described in Sup-
plemental Experimental Procedures.
Flow Cytometry and Cell Sorting
See Supplemental Experimental Procedures for detailed descriptions of cell
sorting and surface and intracellular staining of cells. Antibodies used for cell
staining and sorting are described in Table S2.
Co-culture of B and T Cell Subsets
PBMCs were FACS sorted into PD-1+CXCR3+CXCR5+CD4+ T cells, PD-
1+CXCR3CXCR5+CD4+ T cells, CD4CD19+CD21+CD27 naive B cells,
and CD4CD19+CD21+CD27+ MBCs. Each T cell subset (2.5 3 104) was co-
cultured with naive B cells (2.5 3 104) for 12 days or MBCs (2.5 3 104)
for 6 days in complete medium with staphylococcal enterotoxin B (SEB)
(1.5 mg/ml; Sigma-Aldrich). After co-culture, B cell number, phenotype, and
Ig levels in supernatants were assessed. See Supplemental Experimental Pro-
cedures for details.
PBMC Stimulation with P. falciparum-Infected RBC Lysate and
Cytokine Measurement
PBMCs were cultured with naive red blood cells (nRBCs) or iRBCs. After
5 days in culture, PBMCs were analyzed by flow cytometry. Cytokines in
plasma and supernatants of stimulated PBMCs were quantified by Luminex.
See Supplemental Experimental Procedures for details.
Antibody Profiling
As described in Supplemental Experimental Procedures and elsewhere (Da-
vies et al., 2005), protein microarrays (Antigen Discovery) containing 1,087
sequence-verified P. falciparum polypeptides (RTS 100 Escherichia coli HY
kits; Roche) were used to profile P. falciparum-specific IgG responses in
plasma.
Statistical Analysis
Continuous data were compared using the paired or unpaired Student’s t test
and ANOVA. Bonferroni adjustments (t tests) and Sidak adjustments (ANOVA)Cell and Antibody Responses to the Same Infection
+CD38hi; middle), and LLPCs (CD20CD21CD27+CD38hiCD138; right) as a
malaria (acute), and 7dpt.
s (left) and SLPCs (middle; HB to acute) and LLPCs (right; HB to 7dpt).
s (left) and SLPCs (middle; HB to acute) and LLPCs (right; HB to 7dpt).
at 7dpt.
ersus fold change in breadth of IgG response from HB to 7dpt.
sus fold change in total IgG reactivity to 1,087 P. falciparum antigens from HB
**p < 0.01; *p < 0.05.
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were applied to correct for multiple comparisons where appropriate. Correla-
tions were calculated with Pearson correlation coefficient, and their signifi-
cance was determined using Fisher’s Z test. All analyses were performed in
Prism 6.0e (GraphPad Software) or R 3.1.2 (R-Core-Team, 2013). See Supple-
mental Experimental Procedures for a detailed description of protein microar-
ray data analysis.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.09.004.
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